KAT6A and acute myeloid leukemia: This interaction underscores the critical role of structural partnerships over KAT6A enzymatic activity in leukemogenesis, unveiling a KAT6A catalytic-independent mechanism through which KAT6A fusions contributes to AML pathogenesis.